Exome Asset Management is an asset management firm founded in 2018 and based in New York, NY. The firm focuses on investing in the global healthcare industry, including pharmaceuticals, biopharmaceuticals, healthcare services, and medical devices. Exome Asset Management employs a strategy that includes modest leverage and both long and short positions, allowing it to invest broadly across various healthcare sub-sectors and geographies.